Patents by Inventor Marc Fink

Marc Fink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device and method of preparing salt-containing water by reverse osmosis
    Patent number: 11002373
    Abstract: An apparatus that treats salt-containing water by reverse osmosis, in which the salt-containing water is separated into a permeate stream and a concentrate stream, includes an inlet for the salt-containing water; an outlet for the permeate; an outlet for the concentrate, and a reverse osmosis device, wherein the inlet and the outlets are integrated into a base unit adapted for installation in a positionally fixed manner, and the reverse osmosis device is an exchangeable unit detachably connected to the base unit.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: May 11, 2021
    Assignee: BWT AQUA AG
    Inventors: Marc Fink, Jürgen Johann, Mathias Schwaiger
  • DEVICE AND METHOD OF PREPARING SALT-CONTAINING WATER BY REVERSE OSMOSIS
    Publication number: 20190331240
    Abstract: An apparatus that treats salt-containing water by reverse osmosis, in which the salt-containing water is separated into a permeate stream and a concentrate stream, includes an inlet for the salt-containing water; an outlet for the permeate; an outlet for the concentrate, and a reverse osmosis device, wherein the inlet and the outlets are integrated into a base unit adapted for installation in a positionally fixed manner, and the reverse osmosis device is an exchangeable unit detachably connected to the base unit.
    Type: Application
    Filed: January 13, 2017
    Publication date: October 31, 2019
    Inventors: Marc Fink, Jürgen Johann, Mathias Schwaiger
  • Methods of operating a membrane separation device, control devices for a membrane separation device and devices that operate a membrane separation device
    Patent number: 9937468
    Abstract: A method of operating a membrane separation device in a continuous flow process includes in the membrane separation device, separating a supply liquid into a first partial stream and a second partial stream, wherein flow rate of the second partial stream and/or recovery rate of the second partial stream is influenced by at least one influencing variable that varies during operation, and varying the flow rate of the first partial stream to compensate for a change of the at least one influencing variable to control flow rate and/or recovery rate of the second partial stream to a preset value.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: April 10, 2018
    Assignee: BWT Aktiengesellschaft
    Inventors: Andrea Pavan, Jürgen Johann, Marc Fink
  • METHODS OF OPERATING A MEMBRANE SEPARATION DEVICE, CONTROL DEVICES FOR A MEMBRANE SEPARATION DEVICE AND DEVICES THAT OPERATE A MEMBRANE SEPARATION DEVICE
    Publication number: 20130240446
    Abstract: A method of operating a membrane separation device in a continuous flow process includes in the membrane separation device, separating a supply liquid into a first partial stream and a second partial stream, wherein flow rate of the second partial stream and/or recovery rate of the second partial stream is influenced by at least one influencing variable that varies during operation, and varying the flow rate of the first partial stream to compensate for a change of the at least one influencing variable to control flow rate and/or recovery rate of the second partial stream to a preset value.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 19, 2013
    Applicant: BWT Aktiengesellschaft
    Inventors: Andrea Pavan, Jürgen Johann, Marc Fink
  • Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
    Patent number: 7652046
    Abstract: The present invention comprises methods for the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders through the administration of compounds of formula (I) and formula (II) which are useful as inhibitors of human casein kinase I?. Pharmaceutical compositions comprising compounds of formula (I) or formula (II) as well as methods for their preparation are also disclosed and claimed.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: January 26, 2010
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: David Marc Fink, Yulin Chiang, Nicola Dawn Collar
  • Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase I?
    Patent number: 7626027
    Abstract: The present invention discloses and claims compounds of formula (I) wherein M is N, and K and L are each C with the remaining substituents further defined herein. These compounds are effective as inhibitors of human casein kinase I?, and as such are useful in the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Grant
    Filed: April 21, 2008
    Date of Patent: December 1, 2009
    Assignee: Aventis Pharmaceuticals Inc
    Inventors: William A. Metz, Jr., Frank Halley, Gilles Dutruc-Rosset, Yong Mi Choi-Sledeski, Gregory Bernard Poli, David Marc Fink, Gilles Doerflinger, Bao-Guo Huang, Ann Marie Gelormini, Juan Anotonio Gamboa, Andrew Giovanni, Joachim E. Roehr, Joseph T. Tsay, Fernando Camacho, William Joseph Hurst, Stephen Wayne Harnish, Yulin Chiang
  • SUBSTITUTED THIENOPYRROLE CARBOXYLIC ACID AMIDES, PYRROLOTHIAZOLE CARBOXYLIC ACID AMIDES, AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I
    Publication number: 20080227822
    Abstract: The present invention comprises methods for the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders through the administration of compounds of formula (I) and formula (II) which are useful as inhibitors of human casein kinase I?. Pharmaceutical compositions comprising compounds of formula (I) or formula (II) as well as methods for their preparation are also disclosed and claimed.
    Type: Application
    Filed: May 22, 2008
    Publication date: September 18, 2008
    Applicant: AVENTIS PHARMACEUTICAL INC.
    Inventors: David Marc FINK, Yulin CHIANG, Nicola Dawn COLLAR
  • SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie
    Publication number: 20080200496
    Abstract: The present invention discloses and claims compounds of formula (I) wherein M is N, and K and L are each C with the remaining substituents further defined herein. These compounds are effective as inhibitors of human casein kinase I?, and as such are useful in the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Application
    Filed: April 21, 2008
    Publication date: August 21, 2008
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William A. METZ, Frank HALLEY, Gilles DUTRUC-ROSSET, Yong Mi CHOI-SLEDESKI, Gregory Bernard POLI, David Marc FINK, Gilles DOERFLINGER, Bao-Guo HUANG, Ann Marie GELORMINI, Juan Antonio GAMBOA, Andrew GIOVANNI, Joachim E. ROEHR, Joseph T. TSAY, Fernando CAMACHO, William Joseph HURST, Stephen Wayne HARNISH, Yulin CHIANG
  • Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
    Patent number: 7402672
    Abstract: The present invention discloses and claims compounds of formula (I) as inhibitors of human casein kinase IF, and methods of using said compounds of formula (I) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: July 22, 2008
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: William A. Metz, Jr., Frank Halley, Gilles Dutruc-Rosset, Yong Mi Choi-Sledeski, Gregory Bernard Poli, David Marc Fink, Gilles Doerflinger, Bao-Guo Huang, Ann Marie Gelormini, Juan Antonio Gamboa, Andrew Giovanni, Joachim E. Roehr, Joseph T. Tsay, Fernando Camacho, William Joseph Hurst, Stephen Wayne Harnish, Yulin Chiang
  • Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
    Patent number: 7393867
    Abstract: The present invention discloses and claims compounds of formula (I) and formula (II), as inhibitors of human casein kinase I? and methods for using said compounds for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) or formula (II) and a method for the preparation of compounds of formula (I) or formula (II) are also disclosed and claimed.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: July 1, 2008
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: David Marc Fink, Yulin Chiang, Nicola Dawn Collar